Study identifier:NIS-ORU-XXX-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
LINE: Treatment patterns in postmenopausaL women with hormone receptor positive breast cancer
local advanced or metastatic postmenopausal breast cancer
N/A
No
-
Female
153
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|